| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5588434 | Metabolism | 2017 | 33 Pages |
Abstract
The findings indicate that NAFPD is a frequent clinical entity, associated with significantly increased risk of metabolic syndrome and its components. The normal pancreatic fat cut-off point of 6.2% may be recommended for use in future prospective studies.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Ruma G. Singh, Harry D. Yoon, Landy M. Wu, Jun Lu, Lindsay D. Plank, Maxim S. Petrov,